Martha Yearsley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Martha Yearsley has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Carla Elena Echeveste
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
3 shared publications - Jianhua Yu
Division of Hematology & Oncology, Department of Medicine, School of Medicine, University of California, Irvine, USA
3 shared publications - Kiyoko Oshima
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA
3 shared publications - Li-Shu Wang
Department of Hematology and Hematopoietic Cell Transplantation, Comprehensive Cancer Center City of Hope National Medical Center Duarte California USA
3 shared publications - Yi-Wen Huang
Department of Pediatrics Medical College of Wisconsin Milwaukee Wisconsin USA
3 shared publications - Athena Dong
Medical School Medical College of Wisconsin Milwaukee Wisconsin USA
2 shared publications
Latest Publications
- 1 November 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (11)
Adipose Tissue Immunosuppressive T Cells Regulate Atherosclerosis Development and Liver Fat Accumulation in Obesity
BACKGROUND: Obesity is associated with a loss of anti-inflammatory regulatory T cells (Tregs) in adipose tissue (AT), resulting in systemic inflammation. The adipocyte is a central modulator of CD4+T-cell subpopulations via antigen presentation through the MHCII (major histocompatibility complex class II). However, the role of adipocyte-induced AT inflammation due to changes in AT Tregs in obesity-related complications, such as atherosclerosis and metabolic-dysfunction-associated fatty liver disease (MAFLD), remains unknown. METHODS: Ldlr (low-density lipoprotein receptor) −/− knockout mice were crossed with adipocyte-specific MHCII knockout (aMHCll [adipocyte MHCII] −/− ) mice to study the effects of AT T-cell changes on atherosclerosis and MAFLD. Metabolic differences, atherosclerotic lesions, liver fat accumulation, and inflammation in adipose, splenic, aortic, and liver tissue were measured in 1-year-old aMHCll −/− Ldlr −/− mice fed a Western high-fat diet for 12 weeks. We used 1-year-old mice because, unlike young mice, they develop markedly accelerated atherosclerosis like humans. RESULTS: Loss of MHCII signaling in adipocytes prevented the obesity-mediated loss of AT Tregs, resulting in decreased insulin resistance, atherosclerosis, and MAFLD. In contrast, depletion of AT Tregs via IL (interleukin)-33 receptor–targeted immunotherapy with ST2 (suppression of tumorigenicity 2) reversed these improvements in Western high-fat diet–fed, 1-year-old aMHCll −/− Ldlr −/− mice, whereas increasing AT Tregs with IL-33 recombinant protein promoted similar beneficial effects as in aMHCll −/− Ldlr −/− mice. Because there were no alterations in splenic Tregs, these differences in atherosclerosis and MAFLD were AT Treg-mediated, independent of peripheral Tregs. Amelioration of insulin resistance, atherosclerosis, and MAFLD was diet- and adipocyte-dependent, as a low-fat, Western diet administered to 1-year-old aMHCll −/− Ldlr −/− mice and myeloid-adipo–specific MHCII knockout mice (m-aMHCll [myeloid-adipocyte MHCII] −/− ) ingesting a Western high-fat diet, had no effect on disease progression. CONCLUSIONS: These results suggest that AT immunosuppressive T cells play a pivotal role in regulating both atherosclerosis development and liver fat accumulation in obesity.
- 1 November 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (11)
Adipose Tissue Immunosuppressive T Cells Regulate Atherosclerosis Development and Liver Fat Accumulation in Obesity
BACKGROUND: Obesity is associated with a loss of anti-inflammatory regulatory T cells (Tregs) in adipose tissue (AT), resulting in systemic inflammation. The adipocyte is a central modulator of CD4+T-cell subpopulations via antigen presentation through the MHCII (major histocompatibility complex class II). However, the role of adipocyte-induced AT inflammation due to changes in AT Tregs in obesity-related complications, such as atherosclerosis and metabolic-dysfunction-associated fatty liver disease (MAFLD), remains unknown. METHODS: Ldlr (low-density lipoprotein receptor) −/− knockout mice were crossed with adipocyte-specific MHCII knockout (aMHCll [adipocyte MHCII] −/− ) mice to study the effects of AT T-cell changes on atherosclerosis and MAFLD. Metabolic differences, atherosclerotic lesions, liver fat accumulation, and inflammation in adipose, splenic, aortic, and liver tissue were measured in 1-year-old aMHCll −/− Ldlr −/− mice fed a Western high-fat diet for 12 weeks. We used 1-year-old mice because, unlike young mice, they develop markedly accelerated atherosclerosis like humans. RESULTS: Loss of MHCII signaling in adipocytes prevented the obesity-mediated loss of AT Tregs, resulting in decreased insulin resistance, atherosclerosis, and MAFLD. In contrast, depletion of AT Tregs via IL (interleukin)-33 receptor–targeted immunotherapy with ST2 (suppression of tumorigenicity 2) reversed these improvements in Western high-fat diet–fed, 1-year-old aMHCll −/− Ldlr −/− mice, whereas increasing AT Tregs with IL-33 recombinant protein promoted similar beneficial effects as in aMHCll −/− Ldlr −/− mice. Because there were no alterations in splenic Tregs, these differences in atherosclerosis and MAFLD were AT Treg-mediated, independent of peripheral Tregs. Amelioration of insulin resistance, atherosclerosis, and MAFLD was diet- and adipocyte-dependent, as a low-fat, Western diet administered to 1-year-old aMHCll −/− Ldlr −/− mice and myeloid-adipo–specific MHCII knockout mice (m-aMHCll [myeloid-adipocyte MHCII] −/− ) ingesting a Western high-fat diet, had no effect on disease progression. CONCLUSIONS: These results suggest that AT immunosuppressive T cells play a pivotal role in regulating both atherosclerosis development and liver fat accumulation in obesity.
- 3 August 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Rectal Hemolymphangioma: A Rare Cause of Hematochezia
Was not provided for this article.
- 3 August 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Rectal Hemolymphangioma: A Rare Cause of Hematochezia
Was not provided for this article.
- Open Access
- 30 March 2022
- Published by Korean Society of Cancer Prevention in Journal of Cancer Prevention
- Vol. 27 (1) , 50-57
Protocatechuic Acid, a Gut Bacterial Metabolite of Black Raspberries, Inhibits Adenoma Development and Alters Gut Microbiome Profiles in ApcMin/+ Mice
Athena Dong, Chien-Wei Lin, Carla Elena Echeveste, Yi-Wen Huang, Kiyoko Oshima, Martha Yearsley, Xiao Chen, Jianhua Yu, Li-Shu Wang. J Cancer Prev 2022;27:50-7. https://doi.org/10.15430/JCP.2022.27.1.50
- 30 March 2022
- Published by Korean Society of Cancer Prevention in Journal of Cancer Prevention
- Vol. 27 (1) , 50-57
Open AccessProtocatechuic Acid, a Gut Bacterial Metabolite of Black Raspberries, Inhibits Adenoma Development and Alters Gut Microbiome Profiles in ApcMin/+ Mice
Athena Dong, Chien-Wei Lin, Carla Elena Echeveste, Yi-Wen Huang, Kiyoko Oshima, Martha Yearsley, Xiao Chen, Jianhua Yu, Li-Shu Wang. J Cancer Prev 2022;27:50-7. https://doi.org/10.15430/JCP.2022.27.1.50
- Open Access
- 30 March 2021
- Published by Korean Society of Cancer Prevention in Journal of Cancer Prevention
- Vol. 26 (1) , 32-40
Dysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in ApcMin/+ Mice: Relation to Metabolism and Gut Microbiota Composition
Yi-Wen Huang,*, Chien-Wei Lin,*, Pan Pan,*, Carla Elena Echeveste, Athena Dong, Kiyoko Oshima, Martha Yearsley, Jianhua Yu,**, Li-Shu Wang,**. J Cancer Prev 2021;26:32-40. https://doi.org/10.15430/JCP.2021.26.1.32
- 30 March 2021
- Published by Korean Society of Cancer Prevention in Journal of Cancer Prevention
- Vol. 26 (1) , 32-40
Open AccessDysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in ApcMin/+ Mice: Relation to Metabolism and Gut Microbiota Composition
Yi-Wen Huang,*, Chien-Wei Lin,*, Pan Pan,*, Carla Elena Echeveste, Athena Dong, Kiyoko Oshima, Martha Yearsley, Jianhua Yu,**, Li-Shu Wang,**. J Cancer Prev 2021;26:32-40. https://doi.org/10.15430/JCP.2021.26.1.32
- Open Access
- 30 June 2020
- Published by Korean Society of Cancer Prevention in Journal of Cancer Prevention
- Vol. 25 (2) , 119-125
Anti-colonic Inflammation by Black Raspberries through Regulating Toll-like Receptor-4 Signaling in Interlukin-10 Knockout Mice
Yi-Wen Huang, Carla Elena Echeveste, Kiyoko Oshima, Jianying Zhang, Martha Yearsley, Jianhua Yu, Li-Shu Wang. J Cancer Prev 2020;25:119-25. https://doi.org/10.15430/JCP.2020.25.2.119
- 30 June 2020
- Published by Korean Society of Cancer Prevention in Journal of Cancer Prevention
- Vol. 25 (2) , 119-125
Open AccessAnti-colonic Inflammation by Black Raspberries through Regulating Toll-like Receptor-4 Signaling in Interlukin-10 Knockout Mice
Yi-Wen Huang, Carla Elena Echeveste, Kiyoko Oshima, Jianying Zhang, Martha Yearsley, Jianhua Yu, Li-Shu Wang. J Cancer Prev 2020;25:119-25. https://doi.org/10.15430/JCP.2020.25.2.119
- 1 September 2017
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (9) , 1479
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis
- 1 September 2017
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (9) , 1479
Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis
- Open Access
- 28 May 2009
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 107 (6) , 1097-1106
Nit1 and Fhit tumor suppressor activities are additive
The fragile histidine triad gene (human FHIT , mouse Fhit ) has been shown to act as a tumor suppressor gene. Nit1 and Fhit form a fusion protein, encoded by the NitFhit gene in flies and worms, suggesting that mammalian Nit1 and Fhit proteins, which are encoded by genes on different chromosomes in mammals, may function in the same signal pathway(s). A previous study showed that Nit1 deficiency in knockout mice confers a cancer prone phenotype, as does Fhit deficiency. We have now assessed the tumor susceptibility of Fhit −/− Nit1 −/− mice and observed that double knockout mice develop more spontaneous and carcinogen‐induced tumors than Fhit −/− mice, suggesting that the extent of tumor susceptibility due to Nit1 and Fhit deficiency is additive, and that Nit1 and Fhit affect distinct signal pathways in mammals. Nit1, like Fhit, is present in cytoplasm and mitochondria but not nuclei. Because Fhit deficiency affects responses to replicative and oxidative stress, we sought evidence for Nit1 function in response to such stresses in tissues and cultured cells: when treated with hydroxyurea, the normal kidney‐derived double‐deficient cells appear not to activate the pChk2 pathway and when treated with H2O2, show little evidence of DNA damage, compared with wild type and Fhit − /− cells. The relevance of Nit1 deficiency to human cancers was examined in human esophageal cancer tissues, and loss of Nit1 expression was observed in 48% of esophageal adenocarcinomas. J. Cell. Biochem. 107: 1097–1106, 2009.
- 28 May 2009
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 107 (6) , 1097-1106
Open AccessNit1 and Fhit tumor suppressor activities are additive
The fragile histidine triad gene (human FHIT , mouse Fhit ) has been shown to act as a tumor suppressor gene. Nit1 and Fhit form a fusion protein, encoded by the NitFhit gene in flies and worms, suggesting that mammalian Nit1 and Fhit proteins, which are encoded by genes on different chromosomes in mammals, may function in the same signal pathway(s). A previous study showed that Nit1 deficiency in knockout mice confers a cancer prone phenotype, as does Fhit deficiency. We have now assessed the tumor susceptibility of Fhit −/− Nit1 −/− mice and observed that double knockout mice develop more spontaneous and carcinogen‐induced tumors than Fhit −/− mice, suggesting that the extent of tumor susceptibility due to Nit1 and Fhit deficiency is additive, and that Nit1 and Fhit affect distinct signal pathways in mammals. Nit1, like Fhit, is present in cytoplasm and mitochondria but not nuclei. Because Fhit deficiency affects responses to replicative and oxidative stress, we sought evidence for Nit1 function in response to such stresses in tissues and cultured cells: when treated with hydroxyurea, the normal kidney‐derived double‐deficient cells appear not to activate the pChk2 pathway and when treated with H2O2, show little evidence of DNA damage, compared with wild type and Fhit − /− cells. The relevance of Nit1 deficiency to human cancers was examined in human esophageal cancer tissues, and loss of Nit1 expression was observed in 48% of esophageal adenocarcinomas. J. Cell. Biochem. 107: 1097–1106, 2009.